CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 15 No. 8
 

PSA of 4 to 10 ng/mL Has Significant PPV for Prostate Ca

August 1, 2006

ATLANTA—PSA levels between 4 and 10 ng/mL have a significant positive predictive value (PPV) for finding prostate cancer in men undergoing extended biopsies, according to results of a study presented at the 101st Annual Meeting of the American Urological Association (abstract 468). For men with a normal digital rectal exam (DRE), PSA levels between 4 and 10 ng/mL are associated with a 25% to 68% likelihood of finding some cancer on biopsy, with the PPV varying based on age and PSA level, the study found.

"There are very few diagnostic tests for cancer that perform with a PPV of between 25% and 50%," study investigator Joseph C. Presti, Jr., MD, said at a press conference.

While test performance can be assessed by different criteria, Dr. Presti suggested that PPV is the most clinically relevant measure. "A PPV tells the patient what he wants to know: ‘If my test is positive, what's the chance I have cancer?'" said Dr. Presti, professor of urology, Stanford University School of Medicine.

In their study, Dr. Presti and his colleagues examined outcomes in 999 asymptomatic men age 50 to 79 with PSA levels between 4 and 10 ng/mL who had undergone their first prostate biopsy, a 12-core extended biopsy scheme, at Stanford University. The men in the study were stratified by age, DRE result, and PSA level.

For men in their 50s with a normal DRE, the PPV of PSA for finding any cancer ranged from 36% for a PSA of 4.0-5.9 ng/mL to 45% for a PSA of 8.0-9.9 ng/mL. The PPV for finding a high-grade cancer (Gleason score 7 or higher) was 14% to 23%. Numbers were comparable for men age 60 to 69. PSA was more predictive for men age 70 to 79, for whom the PPV was 50% to 68% for detecting any cancer and 26% to 53% for detecting high-grade cancer.

As would be expected, PSA was more predictive for men with abnormal DREs, for whom the PPV was 50% to 60% for having any cancer and 25% to 45% for having high-grade cancer. However, Dr. Presti said, PSA is less important for men with an abnormal DRE, as a biopsy is always warranted in that situation.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Vantage Point

STEPHEN J. FREEDLAND, MD —Dr. Freedland, clinical instructor of urology, Johns Hopkins School of Medicine, commented on the study: "I think this study showed very nicely that, independent of age, as PSA went up, the likelihood of finding cancer went up. The message of this study is something we should worry about, because the definition of high vs low PSA is still being debated. I think in the older patient, a slightly high PSA level might not be as worrisome . . . but in a very young patient who has 20 or 30 years to live, you want to find that cancer, in my opinion, and you want to find it early."






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy